Nano Holdings, Inc.
Financial Summary for the Second Quarter of the Fiscal Year Ending March 2027 (Interim) [Japanese GAAP] (Consolidated)
Interim net sales were 77,948 thousand yen (up 89.7% year-over-year), while operating loss widened to -697,886 thousand yen, ordinary loss to -700,373 thousand yen, and net loss attributable to owners of parent for the interim period to -767,435 thousand yen. The group, centered on investment business, is expanding operations in areas such as nucleic acid therapeutics and collaborates with overseas partners centered on NBI. Cash decreased and investment securities increased at the end of the interim period, resulting in total assets of 5,117,900 thousand yen, total liabilities of 1,759,951 thousand yen, and net assets of 3,357,949 thousand yen. Earnings forecasts are not disclosed due to the nature of the investment business; the company will disclose timely information in quarterly, interim and full-year results. Supplementary earnings materials will be prepared and published.
Key Figures
- Net Sales: 77,948 thousand yen (Up 89.7% year-over-year)
- Operating Loss: -697,886 thousand yen
- Interim Net Loss: -767,435 thousand yen
- Total Assets: 5,117,900 thousand yen
AI要約
Overview of Results
While net sales for the interim period achieved a significant year-over-year increase, expenses and impairments inherent to the investment business expanded operating, ordinary, and net losses. The company is advancing a platform strategy that leverages new investments and partnerships, focusing on drug discovery and business development in nucleic acid therapeutics and mRNA-related fields. A decrease in cash and deposits and an increase in investment securities indicate there is room for improvement in the financial position. The company has chosen not to disclose earnings forecasts and will provide timely disclosures in quarterly, interim, and full-year reports. Preparation and publication of supplementary earnings briefing materials and explanatory videos are planned.
Outlook and Capital Policy
The medium- to long-term growth strategy is to accelerate global expansion by strengthening the investment platform business and utilizing overseas networks. Through promotion of investment projects including NANO Bridge I and expansion of collaboration with strategic partners, the company aims to enhance corporate value. Although the financial summary does not disclose earnings forecasts, timely information disclosure will be provided in quarterly, interim, and full-year results to ensure transparency for investors.
Nano Holdings, Inc.
Company overview · Stock price · Financial data · All IR
